Basal Cell Carcinoma

  • D. S. Sarnoff
  • G. L. Peck
Part of the UICC International Union Against Cancer book series (UICCI)

Abstract

There are many excellent methods for the effective treatment of a primary basal cell carcinoma (BCC), the most common of which are (1) curettage and electrodesiccation (C and D), (2) cryosurgery using liquid nitrogen (3) radiation therapy, and (4) surgical excision with primary closure or resurfacing using skin flaps or skin grafts (1–9). The choice of initial therapy for a BCC depends on numerous factors, including its anatomic location, size, clinical characteristics, histologic features, age and medical condition of the patient, anticipated cosmetic result, previous treatment history, and comfort, duration, and cost of treatment. It has been reported that the cure rates with each of the four standard modalities mentioned above approach 95% for simple, primary BCC. Although all of these methods can effectively destroy BCC, in certain situations one method may be preferable to the others.

Keywords

Arsenic Neuropathy Interferon Doxorubicin Methotrexate 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Stegman SJ (1986) Basal cell carcinoma and squamous cell carcinoma: recognition and treatment. Med Clin North Am 70 (1): 95–107PubMedGoogle Scholar
  2. 2.
    Cottel WI (1986) Skin tumors I: Basal and squamous cell carcinomas. Sel Read Plast Surg 4 (6): 6–22Google Scholar
  3. 3.
    Haynes HA, Mead KW, Goldwyn RM (1985) Cancers of the skin. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: Principles and practice of oncology, 2nd edn. Lippincott, Philadelphia, pp 1343–1369Google Scholar
  4. 4.
    Browder JP, Tomsick RS (1983) Basal cell epithelioma: types, treatment methods, and prognosis. Postgrad Med 73 (2): 161–168PubMedGoogle Scholar
  5. 5.
    Swanson NA (1983) Basal cell carcinoma. Treatment modalities and recommendations. Prim Care 10: 443–458PubMedGoogle Scholar
  6. 6.
    Witkowski JA, Parish LC (1982) Basal cell cancer: a curable malignancy. Drug Ther 12(11): 159–161, 164–165Google Scholar
  7. 7.
    Albright SD (1982) Treatment of skin cancer using multiple modalities. J Am Acad Dermatol 7: 143–171PubMedCrossRefGoogle Scholar
  8. 8.
    Casson P (1980) Basal cell carcinoma. Clin Plast Surg 7 (3): 301PubMedGoogle Scholar
  9. 9.
    Helm F (ed) (1979) Cancer dermatology. Lea and Febiger, Philadelphia, pp 325–481Google Scholar
  10. 10.
    Epstein E (ed) (1984) Controversies in dermatology. Saunders, Philadelphia, pp 107–133, 163–184Google Scholar
  11. 11.
    Peck GL (1985) Therapy and prevention of skin cancer. In: Saurat JH (ed) Retinoids: new trends in research and therapy. Karger, Basel, pp 345–354Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • D. S. Sarnoff
  • G. L. Peck

There are no affiliations available

Personalised recommendations